Fromtling R A, Shadomy S, Shadomy H J, Dismukes W E
J Clin Microbiol. 1982 Aug;16(2):408-10. doi: 10.1128/jcm.16.2.408-410.1982.
Of 90 clinical isolates of Cryptococcus neoformans studied, 3 were determined to be serotype B/C. The patients from whom these B/C isolates were obtained were identified as never having lived in or visited the areas associated with B/C serotypes. This finding suggests a broader geographic distribution of this serotype group than previously believed. The glycine-cycloheximide-phenol red medium described by Salkin and Hurd (J. Clin. Microbiol. 15:169-171, 1982) was shown to be more accurate in differentiating A/D and B/D serotype pairs of C. neoformans than the creatinine-dextrose-bromthymol blue medium described by Kwon-Chung et al. (Int. J. Syst. Bacteriol. 28:616-620, 1978).
在研究的90株新型隐球菌临床分离株中,有3株被确定为B/C血清型。获得这些B/C分离株的患者被确定从未在与B/C血清型相关的地区居住或到访过。这一发现表明该血清型组的地理分布比之前认为的更广。Salkin和Hurd(《临床微生物学杂志》15:169 - 171, 1982)描述的甘氨酸 - 放线菌酮 - 酚红培养基在区分新型隐球菌的A/D和B/D血清型对方面比Kwon - Chung等人(《国际系统细菌学杂志》28:616 - 620, 1978)描述的肌酐 - 葡萄糖 - 溴麝香草酚蓝培养基更准确。